Verona Pharma
Verona Pharma is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of chronic respiratory diseases. Its lead product candidate is ensifentrine, a first-in-class dual inhibitor of the enzymes phosphodiesterase 3 and 4, designed to provide both bronchodilator and anti-inflammatory effects.
Brand Identity Data
HQ Country
United Kingdom
HQ City
London
EU Headquartered
No
EU Manufactured
No
Stock Exchange
Private
Repair / Recycling
No
Ethical Certifications
None verified
Verified on July 22, 2026